Charles Schwab
KYTH

Charles Schwab’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Charles Schwab’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-78,006
Closed -$5.85M – 3148
2015
Q3 		$5.85M Buy
78,006
+8,618
+12% +$644K 0.01% 1371
2015
Q2 		$5.23M Buy
69,388
+15,761
+29% +$844K 0.01% 1519
2015
Q1 		$2.69M Buy
53,627
+7,616
+17% +$320K ﹤0.01% 1896
2014
Q4 		$1.6M Sell
46,011
-956
-2% -$33.4K ﹤0.01% 2140
2014
Q3 		$1.54M Buy
46,967
+8,941
+24% +$315K ﹤0.01% 2102
2014
Q2 		$1.46M Buy
38,026
+8,370
+28% +$292K ﹤0.01% 2150
2014
Q1 		$1.18M Buy
29,656
+2,685
+10% +$120K ﹤0.01% 2206
2013
Q4 		$1M Buy
26,971
+5,895
+28% +$245K ﹤0.01% 2271
2013
Q3 		$976K Buy
21,076
+3,735
+22% +$112K ﹤0.01% 2223
2013
Q2 		$474K Buy
+17,341
New +$397K ﹤0.01% 2545

Charles Schwab's KYTH Position: Q4 2015 in Review

Charles Schwab sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q4 2015, closing a stake of 78,006 shares — an estimated $5.85M sold.

Charles Schwab first reported a position in KYTH in Q2 2013 and held it in 10 quarters. The position peaked at $5.85M in Q3 2015. 0 funds tracked by Wall St. Rank hold KYTH as of Q4 2015.

  • Charles Schwab reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q4 2015 after selling out during the quarter.
  • Charles Schwab sold 78,006 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q4 2015, an estimated $5.85M.
  • Charles Schwab first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 10 quarters.
  • Charles Schwab's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $5.85M in Q3 2015.
  • 0 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q4 2015.

Based on Charles Schwab's 13F filing for Q4 2015, filed 11 Feb 2016.